Asieris Pharmaceuticals, a China -based biotech company with global aspirations to discover, develop, and commercialize innovative drugs for the treatment of genitourinary tumors and related diseases, announced today that the first patient was enrolled and administered in its global, multi-centered, Phase III clinical trial of its phot
November 11, 2020
· 3 min read